Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02911753 · ClinicalTrials.gov registry record · NA

Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults

A NA study, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT02911753: Completed NA study, sponsored by University of Arizona.

NCT02911753 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02911753, a NA study, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

This study aims to 1) assess the feasibility and acceptability of a prescribed beverage intervention in 50 obese Hispanic adults ages 18-64 years over 6 weeks; and 2) assess preliminary effects of the beverage intervention on cholesterol and triglyceride levels as well as other markers of health such as blood pressure, glucose and markers of inflammation. This project, if successful, will provide early evidence that targeting dietary behavior around beverage intake could be a novel and easily adopted approach to reduce the burden or delay the onset of metabolic abnormalities in obese Hispanic adults. The expected outcome of the proposed project is the identification of feasible and appropriate beverage intervention strategies to improve engagement and adherence to dietary modification approaches for control of metabolic health indicators in this vulnerable ethnic group.

Primary Outcome

The number of Hispanic adults who contact the researchers and express interest in participation.

Interventions

  • OTHER Mediterranean Lemonade
  • OTHER Green Tea
  • OTHER Flavored Water

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-06
Est. Completion 2017-08
Phase NA
University of Arizona

349 total trials

What the finished NCT02911753 record still lists

NCT02911753 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 3 interventions - of which Mediterranean Lemonade is the first listed.

NCT02911753 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02911753 about?

NCT02911753 is a clinical study titled "Feasibility and Acceptability of a Beverage Intervention for Hispanic Adults". This study aims to 1) assess the feasibility and acceptability of a prescribed beverage intervention in 50 obese Hispanic adults ages 18-64 years over 6 weeks; and 2) assess preliminary effects of the beverage intervention on cholesterol and triglyceride levels as well as other markers of health suc...

What is the current status of trial NCT02911753?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-06. Estimated completion is 2017-08.

What interventions are being tested in trial NCT02911753?

The interventions under investigation include: Mediterranean Lemonade (OTHER), Green Tea (OTHER), Flavored Water (OTHER).

Who is sponsoring clinical trial NCT02911753?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02911753's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02911753, the US trial registry maintained by the National Library of Medicine. NCT02911753 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.